MedPath

Rasagiline Tablets Special Drug Use-Results Survey Survey on Long-term Safety

Not Applicable
Completed
Conditions
Parkinson's disease
Registration Number
JPRN-jRCT1080224120
Lead Sponsor
TAKEDA PHARMACEUTICAL COMPANY LTD.
Brief Summary

o new concerns regarding the long-term safety or efficacy of this drug in participants with Parkinson's disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
1021
Inclusion Criteria

Patients with Parkinson's disease should be surveyed.

Exclusion Criteria

- Participants who have contraindications on package insert of rasagiline.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath